Found: 2
Select item for more details and to access through your institution.
The role of emicizumab, a bispecific factor IXa- and factor X-directed antibody, for the prevention of bleeding episodes in patients with hemophilia A.
- Published in:
- Therapeutic Advances in Hematology, 2018, v. 9, n. 10, p. 319, doi. 10.1177/2040620718799997
- By:
- Publication type:
- Article
Eltrombopag-based combination treatment for immune thrombocytopenia.
- Published in:
- Therapeutic Advances in Hematology, 2018, v. 9, n. 10, p. 309, doi. 10.1177/2040620718798798
- By:
- Publication type:
- Article